Search

Search any products, services and so on here.

About 19662 result(s)

Global Fezolinetant API Market Research Report 2024

  • Nov 05, 24
  • ID: 655397
  • Pages: 85
  • Figures: 85
  • Views: 0
  • From $2,900

Fezolinetant API (active pharmaceutical ingredient) refers to the biologically active component of fezolinetant, a medication specifically developed to treat vasomotor symptoms associated with menopause, such as hot flashes and night sweats. The global Fezolinetant API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecas...


Global Aprepitant Preparations Market Research Report 2024

  • Nov 05, 24
  • ID: 655393
  • Pages: 80
  • Figures: 86
  • Views: 2
  • From $2,900

Aprepitant preparations refer to the various formulations of the medication aprepitant, which is primarily used to prevent nausea and vomiting associated with chemotherapy, surgery, and other medical treatments. Available in both oral and intravenous forms, aprepitant is often combined with other antiemetic agents, such as serotonin (5-HT3) antagonists and corticosteroids, to enhance its effective...


Global Neurokinin Receptor Antagonists for Vasomotor Symptoms Market Research Report 2024

  • Nov 05, 24
  • ID: 655391
  • Pages: 68
  • Figures: 77
  • Views: 2
  • From $2,900

Neurokinin receptor antagonists for vasomotor symptoms are a class of medications designed to alleviate menopausal symptoms such as hot flashes and night sweats, which are primarily caused by hormonal fluctuations. By blocking these receptors, neurokinin receptor antagonists help reduce the frequency and intensity of vasomotor symptoms without the hormonal side effects associated with traditional...


Global Neurokinin Receptor Antagonists Market Research Report 2024

  • Nov 05, 24
  • ID: 655386
  • Pages: 83
  • Figures: 78
  • Views: 0
  • From $2,900

Neurokinin receptor antagonists are a class of medications that inhibit the action of neurokinins by blocking their receptors, primarily neurokinin-1 (NK1) and neurokinin-3 (NK3) receptors. By preventing the binding of neurokinins like substance P and neurokinin B, these antagonists effectively reduce symptoms such as vasomotor symptoms, nausea and vomiting. The global Neurokinin Receptor Antagoni...


Global NK-1 Receptor Antagonists Market Research Report 2024

  • Nov 05, 24
  • ID: 655378
  • Pages: 99
  • Figures: 105
  • Views: 2
  • From $2,900

NK-1 receptor antagonists are a class of drugs that block the neurokinin-1 (NK1) receptors, which are activated by the neurotransmitter substance P. Substance P plays a key role in the body's vomiting reflex, as well as in pain perception and stress responses. By inhibiting NK1 receptors, these drugs are primarily used to prevent and treat nausea and vomiting, particularly those caused by chemothe...


Global Cholinesterase Inhibitors for Alzheimer's Disease Market Research Report 2024

  • Nov 05, 24
  • ID: 655298
  • Pages: 112
  • Figures: 110
  • Views: 0
  • From $2,900

Cholinesterase inhibitors for Alzheimer's disease are a class of medications used to treat symptoms of Alzheimer's disease by enhancing cognitive function and memory. These drugs, including donepezil, rivastigmine, and galantamine, work by inhibiting the enzyme acetylcholinesterase. By increasing acetylcholine levels in the brain, cholinesterase inhibitors aim to improve communication between nerv...


Global Galantamine Tablets Market Research Report 2024

  • Nov 05, 24
  • ID: 655297
  • Pages: 90
  • Figures: 90
  • Views: 0
  • From $2,900

Galantamine tablets are a pharmaceutical form of galantamine, a cholinesterase inhibitor used to treat mild to moderate dementia in patients with Alzheimer's disease.The tablets are typically taken orally and are available in immediate-release,Orally Disintegrating and extended-release formulations, offering flexibility in dosage. The global Galantamine Tablets market was valued at US$ million i...


Global Rivastigmine Tartrate Drug Market Research Report 2024

  • Nov 05, 24
  • ID: 655296
  • Pages: 98
  • Figures: 105
  • Views: 0
  • From $2,900

Rivastigmine tartrate drug is the tartrate salt form of rivastigmine, a cholinesterase inhibitor used in the treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease. Rivastigmine tartrate is available in various forms, including capsules, oral solutions, and transdermal patches, offering flexibility in administration. The global Rivastigmine Tartrate Drug...


Global Donepezil Hydrochloride Tablets Market Research Report 2024

  • Nov 05, 24
  • ID: 655286
  • Pages: 109
  • Figures: 111
  • Views: 3
  • From $2,900

Donepezil hydrochloride tablets are a prescription medication used to treat mild to moderate Alzheimer's disease, classified as a cholinesterase inhibitor. This drug works by increasing levels of acetylcholine, a neurotransmitter crucial for memory and cognitive function, thereby enhancing communication between nerve cells. The tablets are available in two formulations: immediate-release tablets a...


Global Natural APIs (Active Pharmaceutical Ingredients) Market Research Report 2024

  • Nov 05, 24
  • ID: 655276
  • Pages: 87
  • Figures: 83
  • Views: 2
  • From $2,900

Natural APIs (Active Pharmaceutical Ingredients) refer to active substances derived from natural sources that are used in the formulation of pharmaceuticals. These can be extracted from plants, animals, minerals, or microorganisms and often have therapeutic properties. Natural APIs play a significant role in modern medicine, providing effective treatments derived from nature. Their use reflects a...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232